SUPN: Supernus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,510.69
Enterprise Value ($M) 1,447.29
Book Value ($M) 929.17
Book Value / Share 16.90
Price / Book 1.63
NCAV ($M) 169.40
NCAV / Share 3.08
Price / NCAV 8.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio 1.49
Current Ratio 1.73

Balance Sheet (mrq) ($M)
Current Assets 544.32
Assets 1,304.09
Liabilities 374.92
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 607.52
Operating Income 13.40
Net Income 1.32
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 111.08
Cash from Investing 268.73
Cash from Financing -397.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 8.51 6.75
02-14 13G Macquarie Group Ltd 5.01
02-13 13G/A Vanguard Group Inc 11.38 7.34
01-19 13G/A BlackRock Inc. 19.00 8.09

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2023 or ☐ TRANSMISSION REPORT PURSUANT TO
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 85,071 359,039 23.69
2024-05-23 132,585 533,072 24.87
2024-05-22 466,856 204,034 228.81
2024-05-21 186,528 292,474 63.78
2024-05-20 136,071 148,752 91.48

(click for more detail)

Similar Companies
SNSE – Sensei Biotherapeutics, Inc. SPRY – ARS Pharmaceuticals, Inc.
STRO – Sutro Biopharma, Inc. TARA – Protara Therapeutics, Inc.
TBPH – Theravance Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io